Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhanced Non-Specific T Lymphocytes Response to Influenza A (H1N1) AS03-Adjuvanted Vaccine

NCT01178918 is registered in ClinicalTrials.gov with The University Clinic of Pulmonary and Allergic Diseases Golnik as lead sponsor.

NCT NCT01178918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01178918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhanced Non-Specific T Lymphocytes Response to Influenza A (H1N1) AS03-Adjuvanted Vaccine
Lead sponsor
The University Clinic of Pulmonary and Allergic Diseases Golnik
Phase
Observational
Overall status
Completed
Start date
November 30, 2009
Completion date
July 1, 2012
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza h1n1